Compare ARK Genomic Revolution ETF (ARKG) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Unilever plc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Unilever plc trades at $61.45 (market cap $130.72B). The key difference: Unilever plc pays a 3.69% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Unilever plc nearer its low. Which is the better fit depends on your goals.
| ARKG | UL | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $43.57 | $74.59 |
52-Week Low | $23.09 | $55.05 |
Market Cap | — | $130.72B |
Enterprise Value | — | $156.17B |
Dividend Yield | — | 3.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Unilever (UL) trades at $61.72, up 1.2% with a bullish technical signal despite recent earnings misses. The company maintains strong profitability with 18.75% net margins and 53.32% ROE, though revenue declined to $60.76B in 2024. Recent developments include a transformative food business deal with McCormick and a $270M innovation center investment, positioning for future growth amid current headwinds.
UL presents a mixed outlook with strong brand power and cash flow generation offset by recent earnings disappointments and competitive pressures. The stock appears fairly valued at 20.93 P/E, with analyst consensus divided between growth potential from strategic initiatives and concerns about execution risks in a challenging consumer environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
